ELESTAT (Epinastine) ophthalmic solution is convenient to use. The recommended dosage is 1 drop in each eye twice a day. Please keep in mind that treatment should be continued throughout the period of exposure (until pollen season is over or until exposure to the offending allergen ends), even when symptoms are not present. ELESTAT (epinastine HCl ophthalmic solution) 0.05% is an effective anti-allergy therapy that is indicated for the prevention of itching associated with allergic conjunctivitis. An antihistamine with mast cell-stabilizing activity, ELESTAT soothes the eyes with fast-acting and sustained relief of ocular itching, the symptom allergy sufferers complain about most. ELESTAT rapidly relieves ocular itching by blocking the H1- and H2-receptors, stabilizing mast cells, and stopping the progression of proinflammatory mediators. In fact, only ELESTAT ophthalmic solution labeling cites the prevention of histamine binding to both the H1- and H2- receptors.

The most frequently reported ocular adverse events occurring in approximately 1-10% of patients were burning sensation in the eye, folliculosis, hyperemia, and pruritus.

ELESTAT ophthalmic solution is appropriate for use by adults and children 3 years of age and older suffering from ocular itching due to allergic conjunctivitis. The safety and efficacy of ELESTAT® in pediatric patients below the age of 3 years have not been established. ELESTAT has a multiaction effect that inhibits the allergic response 3 ways: Action 1 stabilizes mast cells by preventing mast cell degranulation to control the allergic response. Action 2 prevents histamine binding to both the H1- and H2-receptors to stop itching and provide lasting protection. Action 3 prevents the release of proinflammatory chemical mediators from the blood vessel to halt progression of the allergic response. The multiaction efficacy of ELESTAT ophthalmic solution provides the fast-acting, long-lasting ocular itching relief your patients are looking for.